Global Pharmaceutical Hot Melt Extrusions Market Research Report 2021

Hot-melt extrusion (HME) technology is prominent in the pharmaceutical industry. Of particular interest is the use of HME to disperse active pharmaceutical ingredients (APIs) in a matrix at the molecular level, thus forming solid solutions.

The global Pharmaceutical Hot Melt Extrusions market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Pharmaceutical Hot Melt Extrusions volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pharmaceutical Hot Melt Extrusions market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Pharmaceutical Hot Melt Extrusions Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Twin-Screw Extruder
Single-Screw Extruder

Segment by Application
Research Laboratory
Contract Manufacturing Organization
Pharma Companies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Baker Perkins Ltd
Coperion GmbH
Gabler GmbH & Co. KG
Leistritz AG
Milacron Holdings Corp
Thermo Fisher Scientific Inc
Xtrutech Ltd